Check out a new white paper describing the joint efforts of Hypha and Galchimia, who together successfully synthesised metabolites of...
View Article
Hypha were honoured to be asked to contribute a chapter on “Metabolite Generation and Metabolite Characterization by NMR” in the...
View Article
This is an exciting opportunity for an intern to spend time on a research project to further exemplify the use...
View Article
Hypha are excited to announce they have relocated from Slough to Milton Park in Oxfordshire, one of the largest science...
View Article
Metabolites derived from any human flavin-containing monooxygenase (FMO) subtype can now be produced as a service offering at Hypha. Recombinant...
View Article
Great to see Hypha recognised for producing a glucuronide metabolite of praliciguat (M3) in the paper just out in the...
View Article
Hypha remain fully operational and are monitoring the COVID-19 situation closely. We have implemented a number of measures in response...
View Article
As a leading specialist CRO for drug metabolite provision, Hypha has formed a partnership with Cypex Limited, experts in the...
View Article
We are excited to announce the official launch of our One-Stop Metabolite Shop, which offers a complete solution for pharma...
View Article
Hypha are looking forward to presenting two posters at the ISSX meeting held in Portland US from 28th to 31st...
View Article
